Peringkat dalam Saham
#20226
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research,... Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
Kapitalisasi Pasar
$136.47M
Perubahan (1 hari)
-1.15%
Perubahan (1 tahun)
21.17%
Perdagangan Sinew Pharma Inc. (6634)
Harga 6634 dengan kapitalisasi pasar B
Kapitalisasi pasar dari Sinew Pharma Inc.(6634)
Kapitalisasi Pasar: $136.47M
Per August 2026, Sinew Pharma Inc. memiliki kapitalisasi pasar sebesar $136.47M. Ini menjadikan Sinew Pharma Inc. sebagai perusahaan 20226th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Sinew Pharma Inc. dari 2017 hingga 2026
6634 dibandingkan dengan 5 teratas stocks paling populer
| Harga 6634 |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.088T
|
+3,727,955.11%
|
|
|
|
|
$4.585T
|
+3,359,983.50%
|
|
|
|
|
$4.206T
|
+3,081,974.57%
|
|
|
|
|
$3.632T
|
+2,661,254.48%
|
|
|
|
|
$2.824T
|
+2,069,523.43%
|
